$DSGN 4 SEC Filings

Filed On	Filing
11 Jun 2026	Form 4: George Simeon, Director Granted 30,000 Stock Option (right to buy)
11 Jun 2026	Form 4: Shapiro David, Director Granted 30,000 Stock Option (right to buy)
11 Jun 2026	Form 4: Berger Heather A., Director Granted 30,000 Stock Option (right to buy)
11 Jun 2026	Form 4: Gover Justin D., Director Granted 30,000 Stock Option (right to buy)
11 Jun 2026	Form 4: Schmid John P., Director Granted 30,000 Stock Option (right to buy)
11 Jun 2026	Form 4: Lappe Rodney W, Director Granted 30,000 Stock Option (right to buy)
01 Apr 2026	Form 4: Shapiro David, Director Granted 67,500 Stock option (right to buy)
05 Jan 2026	Form 4: Storgard Chris, Chief Medical Officer Granted 250,000 Stock option (right to buy)
05 Jan 2026	Form 4: Jeffries Sean, Chief Operating Officer Granted 375,000 Stock option (right to buy)
05 Jan 2026	Form 4: Burgess Julie, Chief Accounting Officer Granted 150,000 Stock option (right to buy)
05 Jan 2026	Form 4: Gover Justin D., Director Granted 45,000 Stock option (right to buy)
05 Jan 2026	Form 4: Shah Pratik, Director Granted 750,000 Stock option (right to buy)
11 Dec 2025	Form 4: Shah Pratik, Director Granted 1,050,000 Stock option (right to buy)
10 Sep 2025	Form 4: Gover Justin D., Director Granted 45,833 Stock option (right to buy)
14 Aug 2025	Form 4: William Arsani, Director Sold 562,627 shares ($2.95M)
12 Jun 2025	Form 4: George Simeon, Director Granted 19,000 Stock Option (right to buy)
12 Jun 2025	Form 4: Prasad Deepa, Director Granted 19,000 Stock Option (right to buy)
12 Jun 2025	Form 4: William Arsani, Director Granted 19,000 Stock Option (right to buy)
12 Jun 2025	Form 4: Berger Heather A., Director Granted 19,000 Stock Option (right to buy)
12 Jun 2025	Form 4: Schmid John P., Director Granted 19,000 Stock Option (right to buy)

Comments